Company Financials

JD Health International, Inc. Financials

Euro

business JD Health International, Inc. Company Profile

Main Stock Listing

FSX: 8ZN

Market Capitalization €14.40 Billion as of July 1, 2025

Market Cap History

Valuations Metrics as of Jul. 4, 2025

Trailing PE 27.88
Forward PE
Price to Sales TTM €0.25
Price to Book MRQ €0.25
Enterprise to Revenue -0.62
Enterprise to EBITDA -27.62

Financial Reports as of Dec. 31, 2024

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2024-12-31
Profit Margin 7.16%
Operating Margin 0.43%
Return on Assets TTM 1.07%
Return on Equity TTM 7.95%

Income Statement

Revenue TTM €6,886,711,656
Revenue per Share TTM €18.51
Quarterly Revenue Growth 12.90%
Gross Profit TTM €1,575,868,575
EBITDA €5,335,418,000
Net Income to Common TTM €492,803,944
Diluted EPS TTM €0.16
Quarterly Earnings Growth YoY 266.00%

Balance Sheet

Total Cash MRQ €6,066,817,384
Total Cash per Share MRQ €16.29
Total Debt MRQ
Total Debt to Equity MRQ 0.47
Current Ratio MRQ 3.77
Book Value per Share MRQ €17.56

Cash Flow

Operating Cash Flow TTM €512,995,558
Levered Free Cash Flow TTM €278,615,084

8ZN Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding 3,198,565,111
Float Shares 1,015,054,786
Avg 10 Volume 794
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 67.73%
% Held by Institutions 14.07%

Stock Price Summary

Beta 1.11
Fifty Two Week Low €2.28
Fifty Two Week High €4.78
Fifty Two Week Change 42.73%
Day 50 MA €4.42
Day 200 MA €3.88

Dividends and Splits

Forward Annual Dividend Rate
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate €0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date